In this study, after a comprehensive bioinformatics and experimental analysis of the role of HIC2 in glioma, we found that HIC2 was epigenetically silenced by hypermethylation in its promoter and low expression of HIC2 indicated an unfavorable prognosis. This evidence concerns the gene HIC2 and central nervous system cancer.